Seroflo Inhaler

Utilized to target asthma and COPD to support respiratory function.

Strengths: 25/125 · 25/250mcg

Medicine details

Alternative names

Seretide; Advair Diskus; Advair Rotahaler

Therapeutic class

Long-acting Beta2-agonist / Inhaled Corticosteroid

Pharmacological class

Corticosteroid / Long-acting beta-2 agonist

Contraindications

hypersensitivity to fluticasone or salmeterol

Precautions and warnings

rinse mouth after use; use consistently; avoid abrupt discontinuation

Minor side effects

headache; nasopharyngitis

Moderate side effects

tremor; palpitations; oral candidiasis

Dosage forms

Pressurised inhalation, suspension

Administration route

Inhalation use

Patient summary

Utilized to target asthma and COPD to support respiratory function.

Prescription status

POM

Manufacturer

GSK

Onset Time

15–30 minutes

Duration

12 hours

Storage instructions

Store at room temperature.

Drug interactions

Ketoconazole

Age restrictions

Follow specialist paediatric guidance.

Pregnancy and breastfeeding

Consult your doctor during pregnancy.

Serious side effects

paradoxical bronchospasm — requires immediate medical attention; cardiac arrhythmias — requires immediate medical attention

Mechanism of action

Combines a long-acting beta-agonist to relax airways and an anti-inflammatory corticosteroid to reduce lung swelling, improving overall airflow and control.

Seroflo Inhaler

Utilized to target asthma and COPD to support respiratory function.

Editorial Notes

  • Active ingredient(s): Fluticasone, Salmeterol
  • Listed indication(s): Asthma, Chronic Obstructive Pulmonary Disease

Usually available as

  • 3 inhalers - 25/125 mcg349-25-125-mcg-12194
  • 3 inhalers - 25/250 mcg349-25-250-mcg-11516